{"target":"http://pubannotation.org/docs/sourcedb/PMC/sourceid/3585731/divs/13","sourcedb":"PMC","sourceid":"3585731","divid":13,"text":"Reagents and Chemicals\nNecrostatin analogs were synthesized as previously described [23], [24]. The following reagents and final concentrations (unless otherwise specified in the text/figures) were used in the experiments: Akt inhibitor VIII (10 \u00b5M, Calbiochem), MK-2206 (10 \u00b5M, Selleck Chem), Triciribine (100 \u00b5M, National Cancer Institute), SP600125 (10 \u00b5M, Calbiochem), JNK inhibitor VIII (10 \u00b5M, Calbiochem), UO126 (10 mM, Cayman Chem), PD169316 (10 \u00b5M, Calbiochem), LiCl (10 mM, Sigma), SB216763 (10 \u00b5M, Calbiochem), BX912 (10 \u00b5M, Axon Med Chem), PF-4706871 (Sigma), rapamycin (100 nM, Santa Cruz), PI-103 (10 \u00b5M, Calbiochem), Torin-1 (500 nM, gift of Dr. Nathanael Grey (Harvard Medical School), LY249002 (10 \u00b5M, Cell Signaling), PD173074 (2 \u00b5M, Cayman Chem), PD166866 (20 \u00b5M, Calbiochem), 4EGI-1 (50 \u00b5M, Calbiochem). Pan-caspase inhibitor zVAD.fmk (20\u201330 \u00b5M) was purchased from Bachem. Human and mouse TNF\u03b1 (10 ng/ml), human bFGF (25 ng/ml), EGF (50 ng/ml), PDGF-BB (20 ng/ml), and IGF-1 (50 ng/ml) were from Cell Sciences or Peprotech. All other reagents were from Sigma.","project":"bionlp-st-ge-2016-test-proteins","denotations":[{"id":"T1","span":{"begin":909,"end":913},"obj":"Protein"},{"id":"T2","span":{"begin":932,"end":936},"obj":"Protein"},{"id":"T3","span":{"begin":949,"end":952},"obj":"Protein"},{"id":"T4","span":{"begin":989,"end":994},"obj":"Protein"}]}